(NNOX) – Company Press Releases
-
Nanox Files 2023 Annual Report on Form 20-F
-
Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market
-
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
-
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
-
Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold
-
Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases
-
Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
-
Nanox Mourns Death of Its Founder, Ran Poliakine
-
Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update
-
Nanox to Report Third Quarter 2023 Financial Results on November 28, 2023 and Reschedules Investor Day for December 4, 2023
-
Nanox Continues Business as Planned, and Postpones Investor Day Scheduled for October 17, 2023
-
Nanox Announces Strategic Manufacturing Agreement with Varex Imaging Corporation to Advance the Nanox.ARC Medical Imaging System
-
Nanox to Host Investor Day on October 17, 2023
-
Nanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs
-
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
-
Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
-
Nanox to Report Second Quarter 2023 Financial Results on August 17, 2023
-
Nanox Announces $30 Million Registered Direct Offering
-
Nanox Announces First Quarter of 2023 Financial Results and Provides Business Update
-
Nanox to Report First Quarter 2023 Financial Results on May 22, 2023
-
Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging
-
Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging
-
Nanox Files 2022 Annual Report on Form 20-F
-
Nanox Files 2022 Annual Report on Form 20-F
-
Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health
-
Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health
-
Nanox Announces Fourth Quarter 2022 Financial Results and Provides Business Update
-
Nanox Announces Fourth Quarter 2022 Financial Results and Provides Business Update
-
Nanox to Report Fourth Quarter 2022 Financial Results on March 9, 2023
-
Nanox.AI Connects to Nuance Precision Imaging Network to Improve Early Detection of Chronic Diseases with Workflow-Integrated AI
-
Nanox.AI Connects to Nuance Precision Imaging Network to Improve Early Detection of Chronic Diseases with Workflow-Integrated AI
-
Nanox Announces Third Quarter 2022 Financial Results and Provides Business Update
-
Nanox Announces Third Quarter 2022 Financial Results and Provides Business Update
-
Nanox to Report Third Quarter 2022 Financial Results on November 10, 2022
-
Nanox to Report Third Quarter 2022 Financial Results on November 10, 2022
-
Nanox to Host and Livestream ‘ARC Day’ event: Company’s Demonstration of Nanox’s Ecosystem
-
Nanox to Host and Livestream ‘ARC Day’ event: Company’s Demonstration of Nanox’s Ecosystem
-
Nanox to Present at Two Upcoming Investor Conferences in September 2022
-
Nanox to Present at Two Upcoming Investor Conferences in September 2022
-
Nanox Announces Second Quarter 2022 Financial Results and Provides Business Update
-
Nanox to Report Second Quarter 2022 Financial Results on August 16, 2022
-
Nanox Announces Its First Quarter of 2022 Financial Results and Provides Business Update
-
Nanox to Report First Quarter 2022 Results on May 19, 2022
-
NANO-X IMAGING LTD Files 2021 Annual Report on Form 20-F
-
Nanox Announces FDA Clearance for HealthOST Device, an AI Software Measuring Vertebral Compression Fractures and Low Bone Density, Which are Often Associated with Osteoporosis
-
Nanox Opens South Korean Fabrication Plant to Produce Semiconductor Chips for Novel Digital Nanox.ARC 3D X-ray System
-
Nanox Announces Fourth Quarter 2021 Financial Results and Provides Business Update
-
Nanox to Report Fourth Quarter and Full Year 2021 Results on March 31, 2022
-
Nanox to Present at Two Upcoming Investor Conferences in March 2022
-
Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution
Back to NNOX Stock Lookup
